0.7700USD+0.63%Mkt Cap: 24.36M USDP/E: —Last update: 2026-06-01
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogenei…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap24.36M USD
Enterprise Value9.04M USD
Revenue (TTM)1.22M USD
Gross Profit803.00K USD
Net Income (TTM)-22.70M USD
Revenue/Share0.0610 USD
Last Price0.7700 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees38
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.50
PEG—
EV/EBITDA-0.41
EV/Revenue7.44
P/S20.07
P/B1.48
EPS (TTM)-1.14
EPS (Forward)-1.53
52W Range
0.475022% of range1.800
52W High1.800 USD
52W Low0.4750 USD
Profitability
Gross Margin66.97%
Oper. Margin-1199.75%
EBITDA Margin0.00%
Profit Margin-1893.58%
ROE-400.07%
ROA-221.26%
Growth
Revenue Growth4.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-18.64M USD
CapEx (TTM)595.00K USD
FCF Margin-873.08%
FCF Yield-43.58%
Net Debt-15.01M USD
Net Debt/EBITDA0.69
Balance Sheet
Debt/Equity0.15
Current Ratio3.88
Quick Ratio3.64
Book Value/Sh0.5210 USD
Cash/Share0.5060 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateMar 27, 2024
Analyst Consensus
Rating1.7 (Buy)
Target (Mean)7.150 USD
Target Range3.000 USD – 10.45 USD
# Analysts3
Ownership
Shares Out.30.15M
Float26.53M
Insiders9.72%
Institutions14.05%
Short Interest
Short Ratio4.6d
Short % Float8.03%
Short % Out.7.41%
Shares Short2.34M
Short (prev mo.)2.90M
Technical
SMA 500.9308 (-17.3%)
SMA 2000.7485 (+2.9%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)420.80K
Avg Vol (10d)526.35K
Technical Indicators
RSI (14)44.0
MACD-0.0363
MACD Signal-0.0484
MACD Hist.+0.0121
BB Upper0.9256 USD
BB Middle0.7832 USD
BB Lower0.6407 USD
BB Width36.37%
ATR (14)0.0680 USD
Vol Ratio (20d)0.36x